Document is current
Any future updates will be listed below
-
Authors
Jiang, Nan
Saftics, Andras
Romano, Eugenia
Ghaeli, Ima
Resto, Cristal
Robles, Vanessa
Das, Saumya
Van Keuren-Jensen, Kendall
Seewaldt, Victoria L.
Jovanovic-Talisman, Tijana
-
Funding
Funding for this research was provided by:
National Institutes of Health (TR002878)
National Institutes of Health (TR002878)
National Institutes of Health (TR002878)
Dorrance Family Research Fund
Population Facing Research Shared Resource, City of Hope Comprehensive Cancer Center
Circle 1500
Dancing with Chicago Celebrities
Board of Governors of the City of Hope
Concern Foundation
- License Information
-
More Information
Article History
Received: 21 June 2024
Accepted: 14 September 2024
First Online: 28 September 2024
Declarations
:
: The protocol was approved by the City of Hope Institutional Review Board (number 17185).
: Not applicable.
: Informed consent was obtained from all subjects involved in the study.
: SD is a founding member and holds equity in Thryv Therapeutics and Switch Therapeutics, and has consulted for Renovacor, none of which played any role in this study. Part of methodology used in this work is the subject of a provisional patent application. Patent holders may be entitled to certain compensation through their institutions’ respective intellectual property policies in the event such intellectual property is licensed.
